Related Experiment Video
Updated: Mar 1, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Effect of intensive glucose control on microvascular events in people with type 2 diabetes
Insights
Intensive glucose control in type 2 diabetes may reduce microvascular events. Further research is needed on febrile seizures in children and other medical topics.
Area of Science:
- Endocrinology and Metabolism
- Pediatrics
- Pharmacology
Background:
- Type 2 diabetes management often involves intensive glucose control.
- Febrile seizures are common in children, prompting investigation into prophylactic treatments.
- Gastric acid suppression and its link to Clostridioides difficile infection require ongoing evaluation.
Purpose of the Study:
- To assess the impact of intensive glucose control on microvascular events in type 2 diabetes.
- To review the benefits and risks of prophylactic drug management for febrile seizures in children.
- To explore the evolving landscape of cardiovascular polypills and regulatory actions on generic drugs.
Main Methods:
- Systematic review and meta-analysis for glucose control and microvascular events.
- Evidence-based review for febrile seizure management.
- Analysis of current research and regulatory updates for other topics.
Main Results:
- Intensive glucose control showed a trend towards reducing microvascular events.
- Prophylactic drug management for febrile seizures presents a complex risk-benefit profile.
- Emerging data on C. difficile risk with acid suppression and polypill efficacy.
Conclusions:
- Optimizing glucose control is crucial for preventing diabetic microvascular complications.
- Careful consideration of risks and benefits is essential for pediatric febrile seizure treatment.
- Continuous monitoring of drug safety, efficacy, and regulatory actions is vital in healthcare.
Abstract:
Effect of intensive glucose control on microvascular events in people with type 2 diabetes ● Febrile seizures in children: benefits and risks of prophylactic drug management More on gastric acid suppression and C difficile risk ● What next for the cardiovascular polypill? ● EMA recommends suspension of some generic drugs ● Phototherapy for vitiligo ● WHO targets medication-related errors.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

